Encephalitis, Japanese B Completed Phase 2 Trials for Yellow fever vaccine (DB10805)

Also known as: Japanese Encephalitis / Encephalitis Japanese B / Encephalitis, Japanese / Japanese B encephalitis / Japanese B viral encephalitis

Indication	Status	Phase
DBCOND0033957 (Encephalitis, Japanese B)	Completed	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT00982137	Study of Live Attenuated Japanese Encephalitis Vaccine (ChimeriVax™-JE) and Yellow Fever Vaccine (STAMARIL®)	Prevention	Yellow fever vaccine (DB10805)
NCT01943305	The Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in Humans		Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) (DB10769) Yellow fever vaccine (DB10805)